TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform
Open Special Notice Posted
- Solicitation number
- S-191192
- Agency
-
Department of Energy
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- Los Alamos, New Mexico 87545, United States
- Points of contact
-
- Mike Erickson licensing@lanl.gov
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Energy is licensing the Bacterial Lipid Nanodiscs Platform, a technology developed by Los Alamos National Laboratory for studying bacterial membrane components in nanoscale format, with responses due by December 15, 2026. No set-aside applies.
The platform creates uniform 10-nanometer discs from total lipid extracts harvested directly from bacterial membranes, using membrane scaffold protein MSP1D1 to stabilize the heterogeneous lipid population in a membrane-like environment. The technology enables researchers to study immunogenic lipids and membrane-associated targets without the safety hazards of handling live high-risk pathogens, and preserves native biological context superior to synthetic lipid alternatives. Demonstrated using Yersinia pestis, the platform has successfully identified antibodies specific to E. coli and Y. pestis membrane lipids; those antibody discoveries are independently licensable. The technology is at Technology Readiness Level 3 with a U.S. patent pending.
Potential applications span vaccine design, antimicrobial discovery including therapeutic antibodies to conserved bacterial lipids, drug discovery, diagnostics, and biodefense research. Interested parties should contact LANL's licensing office at licensing@lanl.gov for licensing terms and additional technical information. The technology listing appears on SAM.gov and at m.lanl.gov/tech-search.
Notice text
The Bacterial Lipid Nanodiscs Platform developed by Los Alamos National Laboratory provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. Researchers gain access to membrane components that typically remain difficult to isolate, stabilize or analyze, enabling more accurate evaluation of immunogenic lipids and membrane‑associated targets. The platform offers a safer alternative to handling live high‑risk pathogens while preserving the biological context that drives meaningful insights for vaccine design and antimicrobial discovery such as therapeutic antibodies to conserved lipids on bacterial membranes.
How it Works
The Bacterial Lipid NanodiscsPlatform creates uniform nanoscale discs from total lipid extracts harvested from bacterial membranes. Membrane scaffold protein MSP1D1 encases the lipid mixture and forms a stable disc roughly 10 nanometers wide. The resulting particles retain the full complement of native bacterial lipids, arranged in a membrane‑like environment that supports realistic biological interactions without requiring synthetic lipids or live cells.
Technical Description
The method adapts established nanodisc assembly techniques to incorporate entire bacterial lipid extracts rather than defined synthetic lipid mixtures. Total lipids from a pathogen are solubilized, combined with MSP1D1 and dialyzed under controlled conditions to allow the scaffold protein to form a discoidal structure around the heterogeneous lipid population. The process yields nanoparticles that represent the membrane environment of the source organism, including amphiphilic molecules that typically resist purification or structural study when isolated from their native context.
The approach was demonstrated using Yersinia pestis, chosen to illustrate how membrane characterization can proceed without the hazards associated with live Tier 1 pathogens. The method captures lipopolysaccharides (LPS) and diverse immunogenic lipids in an arrangement that mirrors their natural organization. Researchers can evaluate binding interactions, immune‑stimulating properties and potential antigenic targets in a stable platform that avoids the limitations of outer membrane vesicle purification. Furthermore, using this platform we have identified antibodies specific to E. coli LPS and Y. pestis membrane lipids. These antibodies are independently licensable.
Advantages
• Provides membrane‑like structures using native bacterial lipids
• Avoids the safety challenges of handling live pathogens
• Offers a broader and more realistic lipid environment than synthetic nanodiscs
• Enables improved assessment of membrane antigens and immune responses
• Supports analysis of diverse bacterial species using a unified workflow
• Creates consistent nanoscale particles suitable for research and development settings
Market Applications
• Life Sciences Research (membrane biology, immunology)
• Vaccine Development (bacterial antigen discovery)
• Drug Discovery (membrane‑associated targets)
• Diagnostics (lipid biomarker exploration)
• Biodefense Research (safe pathogen characterization)
Development Status: TRL 3
U.S. Patent pending
LA-UR-26-24920
LANL Tech Partnerships: Unlock the Innovative Potential
Los Alamos National Laboratory offers a wide range of cutting-edge technologies and capabilities that may provide your company with a competitive edge in the market and unlock the innovative potential that can enhance, refine, and revolutionize your products.
LANL’s licensing program focuses on moving inventions developed by our researchers to commercial innovations. Patented and patent pending inventions and copyrighted software are available to existing and start-up companies through exclusive and non-exclusive licensing agreements. For specific discussions, please contact licensing@lanl.gov.
Note: This is not a call for external services for the development of this technology.
https://www.lanl.gov/engage/collaboration/feynman-center/partner-with-us/licensing-technology
m.lanl.gov/tech-search
Files
| File | Type | Posted |
|---|---|---|
| Tech-Snapshot-Bacterial-Lipid-26-24920.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| TECHNOLOGY LICENSING OPPORTUNITY: NanoFET | Department of Energy | No set-aside | |
| TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter | Department of Energy | No set-aside | |
| TECHNOLOGY LICENSING OPPORTUNITY: SignalGen | Department of Energy | No set-aside | |
| TIDAL: Target-Induced Droplet Assembly of Ligands | Department of Energy | No set-aside | |
| TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro | Department of Energy | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity